Cargando…

PET Imaging of FSHR Expression in Tumors with (68)Ga-Labeled FSH1 Peptide

FSHR is an appealing target for cancer theranostics. Radiolabeled FSH1 and its derivatives have shown potential to in vivo detect FSHR expression. However, moderate labeling yields (~50% nondecay-corrected) may partially limit their wide use. (68)Ga is an excellent PET nuclide due to availability, n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Donghui, Liu, Guifeng, Xu, Yuping, Wang, Yanting, Yue, Yuanyuan, Wang, Lizhen, Yan, Junjie, Wang, Xinyu, Yang, Runlin, Yang, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612759/ https://www.ncbi.nlm.nih.gov/pubmed/29097913 http://dx.doi.org/10.1155/2017/2674502

Ejemplares similares

(68)Ga-NOTA PET imaging for gastric emptying assessment in mice
por: Chen, Xueyan, et al.
Publicado: (2021)

An Investigation on a Novel Anti-tumor Fusion Peptide of FSH(33-53)-IIKK
por: Yang, Runlin, et al.
Publicado: (2016)

PET of HER2 Expression with a Novel (18)FAl Labeled Affibody
por: Xu, Yuping, et al.
Publicado: (2017)

Synthesis of a novel (89)Zr-labeled HER2 affibody and its application study in tumor PET imaging
por: Xu, Yuping, et al.
Publicado: (2020)

An overview of FSH-FSHR biology and explaining the existing conundrums
por: Bhartiya, Deepa, et al.
Publicado: (2021)

Peptide-Based [(68)Ga]Ga Labeled PET Tracer for Tumor Imaging by Targeting Tumor-Associated Macrophages
por: Huang, Mingxing, et al.
Publicado: (2022)

Endogenous, tissue-resident stem/progenitor cells in gonads and bone marrow express FSHR and respond to FSH via FSHR-3
por: Bhartiya, Deepa, et al.
Publicado: (2021)

(68)Ga-Labeled Cyclic NGR Peptide for MicroPET Imaging of CD13 Receptor Expression
por: Shao, Yahui, et al.
Publicado: (2014)

Differential FSH Glycosylation Modulates FSHR Oligomerization and Subsequent cAMP Signaling
por: Agwuegbo, Uchechukwu T., et al.
Publicado: (2021)

Glycosylation Effects on FSH-FSHR Interaction Dynamics: A Case Study of Different FSH Glycoforms by Molecular Dynamics Simulations
por: Meher, Biswa Ranjan, et al.
Publicado: (2015)

PET imaging of PARP expression using (68)Ga-labelled inhibitors
por: Wang, Xiangwei, et al.
Publicado: (2023)

Doxorubicin loaded ferritin nanoparticles for ferroptosis enhanced targeted killing of cancer cells
por: Yang, Runlin, et al.
Publicado: (2019)

Multifarious Ga-68 Labeled PET Radiopharmaceuticals in Imaging Various Malignancies
por: Vatsa, Rakhee, et al.
Publicado: (2018)

Evaluation of (68)Ga-Radiolabeled Peptides for HER2 PET Imaging
por: Ducharme, Maxwell, et al.
Publicado: (2022)

Preclinical and exploratory human studies of novel (68)Ga-labeled D-peptide antagonist for PET imaging of TIGIT expression in cancers
por: Wang, Xiaobo, et al.
Publicado: (2022)

Development of (68)Ga-labelled ultrasound microbubbles for whole-body PET imaging
por: Hernández-Gil, Javier, et al.
Publicado: (2019)

Synthesis and evaluation of (68)Ga-labeled dimeric cNGR peptide for PET imaging of CD13 expression with ovarian cancer xenograft
por: Yang, Yi, et al.
Publicado: (2021)

[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020)

PET imaging with [(68)Ga]-labeled TGFβ-targeting peptide in a mouse PANC-1 tumor model
por: Li, Yong, et al.
Publicado: (2023)

Targeting HER2-positive gastric cancer with a novel (18)F-labeled Z(HER2:342) probe
por: Pan, Yunyun, et al.
Publicado: (2019)

Highly variable biodistribution of (68)Ga labeled somatostatin analogues (68)Ga-DOTA-NOC and (68)Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT
por: Cheng, Monica, et al.
Publicado: (2022)

(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET
por: Brom, Maarten, et al.
Publicado: (2010)

pH-Responsive Carboxymethylcellulose Nanoparticles for (68)Ga-WBC Labeling in PET Imaging
por: Piras, Anna Maria, et al.
Publicado: (2019)

Recent Advances of (68)Ga-Labeled PET Radiotracers with Nitroimidazole in the Diagnosis of Hypoxia Tumors
por: Nguyen, Anh Thu, et al.
Publicado: (2023)

Determine the Role of FSH Receptor Binding Inhibitor in Regulating Ovarian Follicles Development and Expression of FSHR and ERα in Mice
por: Lai, Luju, et al.
Publicado: (2018)

ImmunoPET imaging of human CD8(+) T cells with novel (68)Ga-labeled nanobody companion diagnostic agents
por: Zhao, Haitao, et al.
Publicado: (2021)

[(68)Ga]Ga-PSMA-11: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
por: Hennrich, Ute, et al.
Publicado: (2021)

Prevalence of Brain Incidental Lesions Detected by (68)Ga-DOTA Peptides PET/CT
por: Albano, Domenico, et al.
Publicado: (2022)

A prospective head-to-head comparison of [(68)Ga]Ga-P16-093 and [(68)Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer
por: Wang, Guochang, et al.
Publicado: (2023)

Synthesis of (68)Ga-Labeled cNGR-Based Glycopeptides and In Vivo Evaluation by PET Imaging
por: Gyuricza, Barbara, et al.
Publicado: (2021)

Optimized (68)Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer
por: Wu, Yitian, et al.
Publicado: (2022)

(68)Ga-labeled amphiphilic polymer nanoparticles for PET imaging of sentinel lymph node metastasis
por: Chen, Qin, et al.
Publicado: (2023)

Voxel-based comparison of [(68)Ga]Ga-RM2-PET/CT and [(68)Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
por: Fassbender, Thomas Franz, et al.
Publicado: (2020)

Corrigendum to “Determine the Role of FSH Receptor Binding Inhibitor in Regulating Ovarian Follicles Development and Expression of FSHR and ERα in Mice”
por: Lai, Luju, et al.
Publicado: (2020)

PET imaging of α(v)β(3) integrin expression in tumours with (68)Ga-labelled mono-, di- and tetrameric RGD peptides
por: Dijkgraaf, Ingrid, et al.
Publicado: (2010)

Accuracy of PET quantification in [(68)Ga]Ga-pentixafor PET/MR imaging of carotid plaques
por: Rausch, Ivo, et al.
Publicado: (2020)

Inadequate detection of the FSHR complicates future research on extragonadal FSHR localization
por: Tedjawirja, Victoria N., et al.
Publicado: (2023)

In vitro and in vivo comparative study of a novel (68)Ga-labeled PSMA-targeted inhibitor and (68)Ga-PSMA-11
por: Chen, Huanyu, et al.
Publicado: (2021)

Localization of Pyelonephritis by (68)Ga-FAPI PET CT
por: Jagtap, Rajlaxmi Rangrao, et al.
Publicado: (2023)

Musculoskeletal pitfalls in (68)Ga-PSMA PET/CT
por: Pontes, Írline Cordeiro de Macedo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q6ptdk93p1nvlkdv9m2rn0gtg3